These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30053818)

  • 21. Olanzapine causes non-alcoholic fatty liver disease via inhibiting the secretion of apolipoprotein A5.
    Li R; Zhu W; Huang P; Ding C; Tang Y; Lian P; Huang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):730-738. PubMed ID: 35837772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillaries.
    Yang Y; Konrad RJ; Ploug M; Young SG
    J Lipid Res; 2024 Jul; 65(7):100578. PubMed ID: 38880127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition.
    Chen YQ; Pottanat TG; Zhen EY; Siegel RW; Ehsani M; Qian YW; Konrad RJ
    J Lipid Res; 2021; 62():100068. PubMed ID: 33762177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumen.
    Yang Y; Beigneux AP; Song W; Nguyen LP; Jung H; Tu Y; Weston TA; Tran CM; Xie K; Yu RG; Tran AP; Miyashita K; Nakajima K; Murakami M; Chen YQ; Zhen EY; Kim JR; Kim PH; Birrane G; Tontonoz P; Ploug M; Konrad RJ; Fong LG; Young SG
    J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37824203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen lowers triglyceride via regulating hepatic APOA5 expression.
    Luo F; Guo Y; Ruan GY; Peng R; Li XP
    Lipids Health Dis; 2017 Apr; 16(1):72. PubMed ID: 28376804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on APOA5 Genetics: Toward a Better Understanding of Its Physiological Impact.
    Guardiola M; Ribalta J
    Curr Atheroscler Rep; 2017 Jul; 19(7):30. PubMed ID: 28500476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
    Chang CK; Lin XR; Lin YL; Fang WH; Lin SW; Chang SY; Kao JT
    PLoS One; 2018; 13(2):e0192740. PubMed ID: 29425239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: studies using genetically engineered mouse models.
    Voshol PJ; Rensen PC; van Dijk KW; Romijn JA; Havekes LM
    Biochim Biophys Acta; 2009 Jun; 1791(6):479-85. PubMed ID: 19168150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of lipid metabolism relative gene polymorphisms and ischemic stroke in Han and Uighur population of Xinjiang.
    Yue YH; Liu LY; Hu L; Li YM; Mao JP; Yang XY; Dila NM
    Lipids Health Dis; 2017 Jun; 16(1):120. PubMed ID: 28623937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional importance of apolipoprotein A5 185G in the activation of lipoprotein lipase.
    Huang YJ; Lin YL; Chiang CI; Yen CT; Lin SW; Kao JT
    Clin Chim Acta; 2012 Jan; 413(1-2):246-50. PubMed ID: 22008704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein A5 inhibits adipogenesis of AMSCs potentially through the Cidec pathway.
    Su X; Peng D; Zheng X
    Int J Cardiol; 2016 Jun; 212():107-8. PubMed ID: 27045875
    [No Abstract]   [Full Text] [Related]  

  • 32. Association and interaction of APOA5, BUD13, CETP, LIPA and health-related behavior with metabolic syndrome in a Taiwanese population.
    Lin E; Kuo PH; Liu YL; Yang AC; Kao CF; Tsai SJ
    Sci Rep; 2016 Nov; 6():36830. PubMed ID: 27827461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOA5 polymorphisms associated with lipid metabolism in Brazilian children and adolescents.
    De França E; Silva DS; Silva TF; Dornelles CL; Alves JG; Alho CS
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
    Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
    J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
    Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
    Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein A-V; a potent triglyceride reducer.
    Nilsson SK; Heeren J; Olivecrona G; Merkel M
    Atherosclerosis; 2011 Nov; 219(1):15-21. PubMed ID: 21831376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association study of Apolipoprotein A5 gene (APOA5 gene) variant with the metabolic syndrome in local Pakistani population.
    Fiaz M; Shaiq PA; Raj GK; Saqlain M; Mehmood A; Naqvi SMS; Cheung BK
    J Pak Med Assoc; 2019 Mar; 69(3):301-305. PubMed ID: 30890818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Association of Apolipoprotein A5-1131T>C Polymorphism with Traits of Metabolic Syndrome.
    Zafar U; Khaliq S; Lone KP
    J Coll Physicians Surg Pak; 2019 Jul; 29(7):626-630. PubMed ID: 31253212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metformin reduces plasma triglycerides in ob/ob obese mice via inhibiting the hepatic apoA5 expression].
    Huang X; Li R; Chen L; Dai W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 42(12):1389-1394. PubMed ID: 29317579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients.
    Horvatovich K; Bokor S; Baráth A; Maász A; Kisfali P; Járomi L; Polgár N; Tóth D; Répásy J; Endreffy E; Molnár D; Melegh B
    Int J Pediatr Obes; 2011 Jun; 6(2-2):e318-25. PubMed ID: 20883102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.